FdaApplication
NDA 211302
Identifiers
- fda_app_no: NDA211302
Properties
| Property | Value |
|---|---|
| applicant_name | RECORDATI RARE DISEASES INC |
| application_type | NDA |
| approval_date | 2020-08-19 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| CYSTADROPS | CYSTEAMINE HYDROCHLORIDE | EQ 0.37% BASE | SOLUTION/DROPS;OPHTHALMIC |
1 product